Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)

INTRODUCTION. Pharmacogenetic (PGx) testing plays a significant role in predicting the risk of adverse drug reactions (ADRs) associated with valproic acid (VPA) products, which are among the most prescribed medicinal products in neurology and psychiatry. However, the sensitivity and specificity of P...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	N. A. Shnayder, V. V. Grechkina, V. V. Arkhipov, R. F. Nasyrova
Format:	Artigo
Sprog:	Russo
Udgivet:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-07-01
Serier:	Безопасность и риск фармакотерапии
Fag:	valproic acid valproate-induced adverse reactions ethnicity genetic polymorphisms allelic variants cytochrome p450 pharmacogenetic testing pharmacogenetic panel personalised medicine
Online adgang:	https://www.risksafety.ru/jour/article/view/423
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!